In the present study, we confirmed a high expression of MALAT1, a well-studied oncogenic lncRNA in lung cancer, is associated with poorer clinicopathologic features, which has inspired us to further investigate the potential role of MALAT1 in chemo-resistance of lung cancer cells. Here, MALAT1 is linked to lung cancer.